You are here: Industry Insights > Advaite

News List

FDA GRANTS ADVAITE EMERGENCY USE AUTHORIZATION FOR RapCov™ Rapid COVID-19 Test prnewswire
January 13, 2021
The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE Inc., an innovative biotech company developing novel point-of-care assays to help with ...
FDA Grants Advaite Emergency Use Authorization FOR RapCov Rapid COVID-19 Test americanpharmaceuticalreview
January 13, 2021
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE.
ADVAITE CLIA Lab Receives Authorization to Offer COVID-19 SalivaDirect Test americanpharmaceuticalreview
November 23, 2020
ADVAITE announced the company's high complexity CLIA laboratory operating out of Chicago, IL has been authorized to offer Yale University's SalivaDirect™ test.
Advaite Produces COVID-19 Rapid Response Diagnostic Kits contractpharma
March 16, 2020
Diagnostic testing kit, ADVAITE RAPCOV, has ability to provide results in 15-30 minutes from a drop of fingertip blood and offers a solution for mass screening.